Drug profile · INN
bazedoxifene
CONBRIZA
bazedoxifene (CONBRIZA) is a estrogen receptor modulator.
EMA: approved Genito-urinary system and sex hormones (G03) G03XC02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — bazedoxifene
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
bazedoxifene (CONBRIZA) is a estrogen receptor modulator.
Key facts
INN bazedoxifene
Brand CONBRIZA
Mechanism Estrogen receptor modulator
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03XC02
Mechanism of action
Estrogen receptor modulator
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bazedoxifene?
bazedoxifene (CONBRIZA) is a estrogen receptor modulator.
What is the brand name for bazedoxifene?
CONBRIZA is a marketed brand name for bazedoxifene. Check FDA Drugs@FDA for the current US label holder and prescribing information.